National Institutes of Health logo
Program

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.

National Institutes of HealthGlobalCooperative agreement

The standard way to find out which drugs a tuberculosis strain will respond to is a culture-based test, and culture is slow — slow enough that a patient can be on the wrong drug for weeks before anyone finds out. This notice funds replacing that wait.

The targets are drug susceptibility tests for mycobacterial drugs generally: drugs already used against tuberculosis and against clinically importa

BiotechMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 27 Aug 2026Source: www.grants.gov